Gene_1_symbol(5end_fusion_partner)	Gene_2_symbol(3end_fusion_partner)	Fusion_description	Counts_of_common_mapping_reads	Spanning_pairs	Spanning_unique_reads	Longest_anchor_found	Fusion_finding_method	Fusion_point_for_gene_1(5end_fusion_partner)	Fusion_point_for_gene_2(3end_fusion_partner)	Gene_1_id(5end_fusion_partner)	Gene_2_id(3end_fusion_partner)	Exon_1_id(5end_fusion_partner)	Exon_2_id(3end_fusion_partner)	Fusion_sequence	Predicted_effect
SIDT2	TAGLN	banned,known,adjacent,conjoing,healthy,cacg,bodymap2,hpa,chimer4seq,cancer,mitelman,1K<gap<10K,readthrough,exon-exon	0	41	8	21	BOWTIE	11:117195915:+	11:117203002:+	ENSG00000149577	ENSG00000149591	ENSE00001678826	ENSE00000991541	TCTCCTCCATCGCCATGTTCGGGTCCTTCCTG*CTTTCCCCAGACATGGCCAACAAGGGTCCTTC	CDS(truncated)/UTR
AZGP1	GJC3	banned,known,adjacent,healthy,cacg,bodymap2,hpa,m36,mitelman,10K<gap<100K,readthrough,exon-exon	0	38	4	21	BOWTIE	7:99971746:-	7:99923603:-	ENSG00000160862	ENSG00000176402	ENSE00001055051	ENSE00001231504	AGACATCGTGGAGTATTACAACGACAGTAACG*TTCCAGGAAGAAGCTTAGCCCAGGAAAAACAA	in-frame
CTBS	GNG5	banned,known,adjacent,conjoing,healthy,cacg,bodymap2,non_tumor_cells,hpa,1000genomes,mitelman,ccle3,10K<gap<100K,readthrough,exon-exon	0	19	6	21	BOWTIE	1:84563257:-	1:84501970:-	ENSG00000117151	ENSG00000174021	ENSE00003547480	ENSE00003459775	AAGATCAGCGGGCTCCTTATTATAACTATAAA*GTTTCCCAGGCAGCTGCAGACTTGAAACAGTT	in-frame
LIMS1	IL3RA	cancer,m2	0	3	6	22	BOWTIE+STAR	2:108686164:+	X:1322974:+	ENSG00000169756	ENSG00000185291			GGAGATCAAGACCATCCTGGCTACCACTGAAACCCCATCTCTACTACAA*AAAAAATTAGCCGGGCGTGGTGGCGGGCGCCTGTGGTCCCAGCTACTCGG	UTR/intergenic
LIMS1	IL3RA	cancer,m2	0	3	5	22	BOWTIE+STAR	2:108686163:+	X:1325207:+	ENSG00000169756	ENSG00000185291			CAGGAGATCAAGACCATCCTGGCTACCACTGAAACCCCATCTCTACTACA*AAAAAAATTAGCCGGGCGTGGTGGCGGGCACCTGTAGTTCCACCTACTGG	UTR/intergenic
LIMS1	IL3RA	cancer,m2	0	3	3	22	BOWTIE+STAR	2:108686164:+	X:1323859:+	ENSG00000169756	ENSG00000185291			AGGAGATCAAGACCATCCTGGCTACCACTGAAACCCCATCTCTACTACAA*AAAAAATTAGCCGGGCGTGGTGGTGGGCGCCTGTAGTCCCAGCTACTCGG	UTR/intergenic
LIMS1	IL3RA	cancer,m2	0	3	3	21	BOWTIE+STAR	2:108686165:+	X:1334701:+	ENSG00000169756	ENSG00000185291			GGAGATCAAGACCATCCTGGCTACCACTGAAACCCCATCTCTACTACAAA*AAAAATTAGCCGGGCGTGGTGGCAGGTGCCCGTAATCCCAGCTACTTGGG	UTR/intergenic
LIMS1	IL3RA	cancer,m2	0	3	3	21	BOWTIE+STAR	2:108686165:+	X:1327236:+	ENSG00000169756	ENSG00000185291			GGAGATCAAGACCATCCTGGCTACCACTGAAACCCCATCTCTACTACAAA*AAAAATTAGCCGGGCGTGGTGGTGTGCACCTGTCATCCCAGCTACTCAGG	UTR/intergenic
EEF1D	WTIP	oncogene,exon-exon	0	2	2	19	BOWTIE	8:143590645:-	19:34500129:+	ENSG00000104529	ENSG00000142279	ENSE00002186055	ENSE00002751039	CGCCTCGGCCTCCCAAAGTGTTGGGATTACAG*GACTGCGGGCTGCAGCTGAGCGGGGAGGAGGG	UTR/CDS(truncated)
MYMX	SLC29A1	adjacent,cancer,1K<gap<10K,readthrough,exon-exon	0	2	3	22	BOWTIE	6:44216968:+	6:44227263:+	ENSG00000262179	ENSG00000112759	ENSE00002665155	ENSE00003472452	CAGAGACTGATTCTGAGCAGCAGTTCTGCCCG*GCCCCTGAGGGAGGGAGCTGTCAGCCAGGGAA	UTR/UTR
MYMX	SLC29A1	adjacent,cancer,1K<gap<10K,readthrough,exon-exon	0	2	3	20	BOWTIE	6:44216968:+	6:44227260:+	ENSG00000262179	ENSG00000112759	ENSE00002665155	ENSE00001456062	CAGAGACTGATTCTGAGCAGCAGTTCTGCCCG*CAGGCCCCTGAGGGAGGGAGCTGTCAGCCAGG	UTR/UTR
